𝔖 Bobbio Scriptorium
✦   LIBER   ✦

878-3 Subgroup analysis of the impact of the glycoprotein IIb/IIIa inhibitor abciximab in patients undergoing elective stent placement >2 hours after treatment with a 600 milligram loading dose of clopidogrel: Results from the ISAR REACT trial

✍ Scribed by Peter B Berger; Adnan Kastrati; Julinda Mehilli; Helmut Schuhlen; Josef Dirschinger; Franz Dotzer; Jurrien M ten Berg; Franz-Josef Neumann; Hildegard Bollwein; Christian Volmer; Meinrad Gawaz; Albert Schomig

Book ID
119548236
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
66 KB
Volume
43
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abciximab and angiographic restenosis af
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT—A double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel
✍ Helmut Schühlen; Adnan Kastrati; Julinda Mehilli; Jörg Hausleiter; Josef Dirschi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 163 KB